Yayın:
Addition of thalidomide (t) to oral melphalan/prednisone (mp) in patients with multiple myeloma: Initial results of a randomized trial from the Turkish myeloma study group.

Basit Görünüm
dc.contributor.authorBeksaç, Mehmet Sinan
dc.contributor.authorHaznedar, Rauf
dc.contributor.authorFıratlı, Tülin Tuğlular
dc.contributor.authorÖzdoğu, Hakan
dc.contributor.authorAydoğdu, İsmet
dc.contributor.authorKonuk, Nahide
dc.contributor.authorSucak, Gulşan Ayhan
dc.contributor.authorKaygusuz, Işık
dc.contributor.authorKarakuş, Savaş
dc.contributor.authorKaya, Emin
dc.contributor.authorGülbaş, Zafer
dc.contributor.authorÖzet, Gülsüm
dc.contributor.authorGöker, Hakan
dc.contributor.authorÜndar, Levent
dc.contributor.buuauthorAli, Rıdvan
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentİç Hastalıkları Ana Bilim Dalı
dc.contributor.departmentHematoloji Ana Bilim Dalı
dc.date.accessioned2022-06-09T06:54:23Z
dc.date.available2022-06-09T06:54:23Z
dc.date.issued2009-11-20
dc.descriptionBu çalışma, 05-08 Aralık 2009 tarihleri arasında New Orleans[Luisana]’da düzenlenen düzenlenen 51. Annual Meeting of the American-Society-of-Hematology’da bildiri olarak sunulmuştur.
dc.description.sponsorshipAmer Soc Hematol
dc.identifier.citationBeksaç, M. vd. (2009). "Addition of thalidomide (t) to oral melphalan/prednisone (mp) in patients with multiple myeloma: Initial results of a randomized trial from the Turkish myeloma study group". Blood, 114(22), 746-747.
dc.identifier.endpage747
dc.identifier.issn0006-4971
dc.identifier.issue22
dc.identifier.startpage746
dc.identifier.urihttp://hdl.handle.net/11452/26995
dc.identifier.volume114
dc.identifier.wos000272725802248
dc.indexed.wosSCIE
dc.indexed.wosCPCIS
dc.language.isoen
dc.publisherAmer Soc Hematology
dc.relation.collaborationYurt içi
dc.relation.collaborationSanayi
dc.relation.journalBlood
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectHematology
dc.subject.wosHematology
dc.titleAddition of thalidomide (t) to oral melphalan/prednisone (mp) in patients with multiple myeloma: Initial results of a randomized trial from the Turkish myeloma study group.
dc.typeOther
dc.type.subtypeMeeting Abstract
dc.wos.quartileQ1
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/İç Hastalıkları Ana Bilim Dalı/Hematoloji Ana Bilim Dalı
local.indexed.atWOS

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama
İndir

Koleksiyonlar

İndeksli Yayınlar / Indexed Publications